1. Lee, J. C.; Laydon, J. T.; McDonnell, P. C.; Gallagher, T. F.; Kumar, S.; Green, D.; McNulty, D.; Blumenthal, M. J.; Keys, J. R.; Landvatter, S. W.; Strickler; J. E.; McLaughlin, M. M.; Siemens, I. R.; Fisher, S. M.; Livi, G. P.; White, J. R.; Adams, J. L.; Young, P. R. Nature, 1994, 372, 739; Rouse, J.; Cohen, P.; Trigon, S.; Morange, M.; Alonso-Llamazares, A.; Zamanillo, D.; Hunt, T.; Nebreda, A. R. Cell, 1994, 78, 1027.
2. Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders
3. The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis
4. p38 Mitogen-Activated Protein Kinase (MAPK) in Rheumatoid Arthritis